Paper3537784
A prospective trial of colchicine for primary biliary cirrhosis.
Kaplan MM and 8 others. N Engl J Med, 1986. Cited by 288 papers, by iCite.
Cite this record
ConductScience Library. A prospective trial of colchicine for primary biliary cirrhosis. Papers, record 3537784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3537784
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colchicine | Major topic |
| Liver Cirrhosis, Biliary | Major topic |
| Alkaline Phosphatase | |
| Bilirubin | |
| Cholesterol | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Liver | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Random Allocation | |
| Serum Albumin | |
| Transaminases |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AM-07024 | NIADDK NIH HHS | United States | PubMed | PubMed | |
| AM-28490 | NIADDK NIH HHS | United States | R01AM028490 | PubMed and NIH | NIH RePORTER |
| M01-RR-00054 | NCRR NIH HHS | United States | M01RR000054 | PubMed and NIH | NIH RePORTER |
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 288 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40568038 | Primary biliary cholangitis: A historical perspective from xanthomatous lesions to modern molecular biology. | World J Gastrointest Pathophysiol | 2025 | https://conductscience.org/library/papers/40568038 | PubMed |
| 39927511 | Colchicine for the primary prevention of cardiovascular events. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/39927511 | PubMed |
| 32982062 | anti-HCoV: A web resource to collect natural compounds against human coronaviruses. | Trends Food Sci Technol | 2020 | https://conductscience.org/library/papers/32982062 | PubMed |
| 32054504 | Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials. | Arthritis Res Ther | 2020 | https://conductscience.org/library/papers/32054504 | PubMed |
| 31936103 | Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/31936103 | PubMed |
| 30429232 | Anticancer effects and underlying mechanism of Colchicine on human gastric cancer cell lines in vitro and in vivo. | Biosci Rep | 2019 | https://conductscience.org/library/papers/30429232 | PubMed |
| 29404429 | Update on pharmacotherapies for cholestatic liver disease. | Hepatol Commun | 2017 | https://conductscience.org/library/papers/29404429 | PubMed |
| 28350426 | Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28350426 | PubMed |
| 27585971 | Colchicine prevents NSAID-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasome. | Sci Rep | 2016 | https://conductscience.org/library/papers/27585971 | PubMed |
| 26816301 | Colchicine for prevention of cardiovascular events. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/26816301 | PubMed |
| 26109432 | Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis. | Oncotarget | 2015 | https://conductscience.org/library/papers/26109432 | PubMed |
| 25759780 | Comparison of sirolimus and colchicine treatment on the development of peritoneal fibrozis in rats having peritoneal dialysis. | Balkan Med J | 2015 | https://conductscience.org/library/papers/25759780 | PubMed |
| 25543678 | Advances in pharmacotherapy for primary biliary cirrhosis. | Expert Opin Pharmacother | 2015 | https://conductscience.org/library/papers/25543678 | PubMed |
| 25343075 | Primary biliary cirrhosis and liver transplantation. | Intractable Rare Dis Res | 2012 | https://conductscience.org/library/papers/25343075 | PubMed |
| 24380894 | Immunosuppressive therapy in immune-mediated liver disease in the non-transplanted patient. | Pharmaceuticals (Basel) | 2013 | https://conductscience.org/library/papers/24380894 | PubMed |
| 24367233 | Natural history and management of primary biliary cirrhosis. | Hepat Med | 2012 | https://conductscience.org/library/papers/24367233 | PubMed |
| 23634279 | Treatment of autoimmune liver disease: current and future therapeutic options. | Ther Adv Chronic Dis | 2013 | https://conductscience.org/library/papers/23634279 | PubMed |
| 23305825 | Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies. | Clin Gastroenterol Hepatol | 2013 | https://conductscience.org/library/papers/23305825 | PubMed |
| 22102382 | The diagnosis and treatment of primary biliary cirrhosis. | Korean J Hepatol | 2011 | https://conductscience.org/library/papers/22102382 | PubMed |
| 19603170 | Primary biliary cirrhosis. | Semin Immunopathol | 2009 | https://conductscience.org/library/papers/19603170 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3537784
GET https://conductscience.org/api/papers/v1/3537784/cited_by?page=2